{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:03:29Z","timestamp":1779800609152,"version":"3.53.1"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02085-6","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T10:14:12Z","timestamp":1758017652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A pain from the nose to the head: neurological commitment during long COVID"],"prefix":"10.1007","volume":"74","author":[{"given":"Laura Cardoso","family":"Corr\u00eaa-Dias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gata","family":"Lopes-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Eduardo Ribeiro","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geovane","family":"Marques-Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio","family":"Wilker-Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Alves","family":"Clarindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"de Melo Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eduarda","family":"Martuchele-F\u00e9lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique Morais","family":"Retes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaiza Aline Pereira","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Lorrany Aparecida","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f4nica Evelyn Viana","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"de F\u00e1tima Silva Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik Vinicius","family":"de Sousa Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia","family":"Gomes-de-Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Frota","family":"Rabelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Augusto Sartori","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Lorran Dias","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Daniela Santos","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Pacheco","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raiany Ara\u00fajo","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Pacheco","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Guimar\u00e3es","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana Grazziela Alves","family":"Coelho-dos-Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"2085_CR1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","volume":"404","author":"T Greenhalgh","year":"2024","unstructured":"Greenhalgh T, Sivan M, Perlowski A, Nikolich J\u017d. Long COVID: a clinical update. Lancet. 2024;404:707\u201324.","journal-title":"Lancet"},{"key":"2085_CR2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133\u201346.","journal-title":"Nat Rev Microbiol"},{"key":"2085_CR3","unstructured":"CDC. Long COVID Basics; 2025. https:\/\/www.cdc.gov\/covid\/long-term-effects\/index.html."},{"key":"2085_CR4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120355","volume":"441","author":"M Michelutti","year":"2022","unstructured":"Michelutti M, Furlanis G, Buoite Stella A, Bellavita G, Frezza N, Torresin G, et al. Sex-dependent characteristics of neuro-long-COVID: data from a dedicated neurology ambulatory service. J Neurol Sci. 2022;441:120355.","journal-title":"J Neurol Sci"},{"key":"2085_CR5","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/jmv.25989","volume":"92","author":"F Zeng","year":"2020","unstructured":"Zeng F, Dai C, Cai P, Wang J, Xu L, Li J, et al. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex. J Med Virol. 2020;92:2050\u20134.","journal-title":"J Med Virol"},{"key":"2085_CR6","volume":"17","author":"BP de Melo","year":"2025","unstructured":"de Melo BP, da Silva JAM, Rodrigues MA, Palmeira JdaF, Saldanha-Araujo F, Arga\u00f1araz GA, et al. SARS-CoV-2 spike protein and long COVID\u2014part 1: impact of spike protein in pathophysiological mechanisms of long COVID syndrome. Viruses. 2025;17:617.","journal-title":"Viruses"},{"key":"2085_CR7","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1093\/cid\/ciac722","volume":"76","author":"Z Swank","year":"2023","unstructured":"Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2023;76:e487\u201390.","journal-title":"Clin Infect Dis"},{"key":"2085_CR8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaci.2024.12.1074","volume":"155","author":"C Skevaki","year":"2025","unstructured":"Skevaki C, Moschopoulos CD, Fragkou PC, Grote K, Schieffer E, Schieffer B. Long COVID: pathophysiology, current concepts, and future directions. J Allergy Clin Immunol. 2025;155:1059\u201370.","journal-title":"J Allergy Clin Immunol"},{"key":"2085_CR9","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","volume":"187","author":"MJ Peluso","year":"2024","unstructured":"Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell. 2024;187:5500\u201329.","journal-title":"Cell"},{"key":"2085_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28568","author":"V Craddock","year":"2023","unstructured":"Craddock V, Mahajan A, Spikes L, Krishnamachary B, Ram AK, Kumar A, et al. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J Med Virol. 2023. https:\/\/doi.org\/10.1002\/jmv.28568.","journal-title":"J Med Virol"},{"key":"2085_CR11","volume-title":"A long COVID definition","year":"2024","unstructured":"Fineberg HV, Brown L, Worku T, Goldowitz I, editors. A long COVID definition. Washington, D.C.: National Academies Press; 2024."},{"key":"2085_CR12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-2600(21)00031-X","volume":"9","author":"P Venkatesan","year":"2021","unstructured":"Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9:129.","journal-title":"Lancet Respir Med"},{"key":"2085_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10072-024-07854-5","volume":"46","author":"SN Narayanan","year":"2025","unstructured":"Narayanan SN, Padiyath S, Chandrababu K, Raj L, Ninan GA, et al. Neurological, psychological, psychosocial complications of long-COVID and their management. Neurol Sci. 2025;46:1\u201323.","journal-title":"Neurol Sci"},{"key":"2085_CR14","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2024.108522","volume":"246","author":"G Furlanis","year":"2024","unstructured":"Furlanis G, Buoite Stella A, Torresin G, Michelutti M, Aj\u010devi\u0107 M, Manganotti P. Neurological long-COVID: associations among fatigue, dysautonomia, depression, and subjective memory complaints. Clin Neurol Neurosurg. 2024;246:108522.","journal-title":"Clin Neurol Neurosurg"},{"key":"2085_CR15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","volume":"8","author":"T Greenhalgh","year":"2024","unstructured":"Greenhalgh T, Sivan M, Perlowski A, Nikolich J. Long COVID: a clinical update. Lancet. 2024;8:707\u201324.","journal-title":"Lancet"},{"key":"2085_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28852","author":"M Rahmati","year":"2023","unstructured":"Rahmati M, Udeh R, Yon DK, Lee SW, Dolja-Gore X, McEVoy M, et al. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: a call to action for neurological, physical, and psychological sciences. J Med Virol. 2023. https:\/\/doi.org\/10.1002\/jmv.28852.","journal-title":"J Med Virol"},{"key":"2085_CR17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/cells12050816","volume":"12","author":"A Leng","year":"2023","unstructured":"Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, et al. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells. 2023;12:816.","journal-title":"Cells"},{"key":"2085_CR18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120162","volume":"434","author":"L Premraj","year":"2022","unstructured":"Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434:120162.","journal-title":"J Neurol Sci"},{"key":"2085_CR19","doi-asserted-by":"crossref","first-page":"611.e9","DOI":"10.1016\/j.cmi.2021.11.002","volume":"28","author":"F Bai","year":"2022","unstructured":"Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul\u00e8 G, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28:611.e9-611.e16.","journal-title":"Clin Microbiol Infect"},{"key":"2085_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr1032","author":"RE Hamlin","year":"2024","unstructured":"Hamlin RE, Pienkos SM, Chan L, Stabile MA, Pinedo K, Rao M, et al. Sex differences and immune correlates of long Covid development, symptom persistence, and resolution. Sci Transl Med. 2024. https:\/\/doi.org\/10.1126\/scitranslmed.adr1032.","journal-title":"Sci Transl Med"},{"key":"2085_CR21","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1016\/S2666-7568(22)00245-8","volume":"3","author":"V Mansell","year":"2022","unstructured":"Mansell V, Hall Dykgraaf S, Kidd M, Goodyear-Smith F. Long COVID and older people. Lancet Healthy Longev. 2022;3:e849\u201354.","journal-title":"Lancet Healthy Longev"},{"key":"2085_CR22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijid.2022.09.035","volume":"125","author":"V Daitch","year":"2022","unstructured":"Daitch V, Yelin D, Awwad M, Guaraldi G, Mili\u0107 J, Mussini C, et al. Characteristics of long-COVID among older adults: a cross-sectional study. Int J Infect Dis. 2022;125:287\u201393.","journal-title":"Int J Infect Dis"},{"key":"2085_CR23","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/s41591-022-02001-z","volume":"28","author":"E Xu","year":"2022","unstructured":"Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28:2406\u201315.","journal-title":"Nat Med"},{"key":"2085_CR24","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/jama.2022.18931","volume":"328","author":"S Wulf Hanson","year":"2022","unstructured":"Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604.","journal-title":"JAMA"},{"key":"2085_CR25","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102\u20137.","journal-title":"Lancet Infect Dis"},{"key":"2085_CR26","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.3399\/BJGP.2021.0265","volume":"71","author":"M Nurek","year":"2021","unstructured":"Nurek M, Rayner C, Freyer A, Taylor S, J\u00e4rte L, MacDermott N, et al. Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. Br J Gen Pract. 2021;71:e815\u201325.","journal-title":"Br J Gen Pract"},{"key":"2085_CR27","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108766","volume":"198","author":"IE Cisneros","year":"2021","unstructured":"Cisneros IE, Cunningham KA. Covid-19 interface with drug misuse and substance use disorders. Neuropharmacology. 2021;198:108766.","journal-title":"Neuropharmacology"},{"key":"2085_CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41583-023-00769-8","volume":"25","author":"J Meinhardt","year":"2024","unstructured":"Meinhardt J, Streit S, Dittmayer C, Manitius Rv, Radbruch H, Heppner FL. The neurobiology of SARS-CoV-2 infection. Nat Rev Neurosci. 2024;25:30\u201342.","journal-title":"Nat Rev Neurosci"},{"key":"2085_CR29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41392-023-01640-z","volume":"8","author":"J Li","year":"2023","unstructured":"Li J, Zhou Y, Ma J, Zhang Q, Shao J, Liang S, et al. The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Signal Transduct Target Ther. 2023;8:416.","journal-title":"Signal Transduct Target Ther"},{"key":"2085_CR30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","volume":"604","author":"G Douaud","year":"2022","unstructured":"Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697\u2013707.","journal-title":"Nature"},{"key":"2085_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073819","author":"LdaS Chagas","year":"2024","unstructured":"Chagas LdaS, Serfaty CA. The influence of microglia on neuroplasticity and long-term cognitive sequelae in long COVID: impacts on brain development and beyond. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25073819.","journal-title":"Int J Mol Sci"},{"key":"2085_CR32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","volume":"595","author":"AC Yang","year":"2021","unstructured":"Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565\u201371.","journal-title":"Nature"},{"key":"2085_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.70009","author":"RS Dos Reis","year":"2024","unstructured":"Dos Reis RS, Selvam S, Ayyavoo V. Neuroinflammation in post COVID-19 sequelae: neuroinvasion and neuroimmune crosstalk. Rev Med Virol. 2024. https:\/\/doi.org\/10.1002\/rmv.70009.","journal-title":"Rev Med Virol"},{"key":"2085_CR34","volume":"42","author":"FL Fontes-Dantas","year":"2023","unstructured":"Fontes-Dantas FL, Fernandes GG, Gutman EG, De Lima EV, Antonio LS, Hammerle MB, et al. SARS-CoV-2 spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep. 2023;42:112189.","journal-title":"Cell Rep"},{"key":"2085_CR35","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41380-020-00965-3","volume":"26","author":"DE Ribeiro","year":"2021","unstructured":"Ribeiro DE, Oliveira-Giacomelli \u00c1, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L, et al. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry. 2021;26:1044\u201359.","journal-title":"Mol Psychiatry"},{"key":"2085_CR36","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1007\/s12035-018-1283-6","volume":"56","author":"B Lima Giacobbo","year":"2019","unstructured":"Lima Giacobbo B, Doorduin J, Klein HC, Dierckx RAJO, Bromberg E, de Vries EFJ. Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation. Mol Neurobiol. 2019;56:3295\u2013312.","journal-title":"Mol Neurobiol"},{"key":"2085_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.1013933","author":"J Yang","year":"2022","unstructured":"Yang J, Ran M, Li H, Lin Y, Ma K, Yang Y, et al. New insight into neurological degeneration: inflammatory cytokines and blood\u2013brain barrier. Front Mol Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnmol.2022.1013933.","journal-title":"Front Mol Neurosci"},{"key":"2085_CR38","first-page":"45","volume":"8","author":"MN Woodroofe","year":"1995","unstructured":"Woodroofe MN. Cytokine production in the central nervous system. Neurology. 1995;8:45.","journal-title":"Neurology"},{"key":"2085_CR39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","volume":"27","author":"C Greene","year":"2024","unstructured":"Greene C, Connolly R, Brennan D, Laffan A, O\u2019Keeffe E, Zaporojan L, et al. Blood\u2013brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024;27:421\u201332.","journal-title":"Nat Neurosci"},{"key":"2085_CR40","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383:2255\u201373.","journal-title":"N Engl J Med"},{"key":"2085_CR41","first-page":"26","volume":"13","author":"JJ Gon\u00e7alves","year":"2022","unstructured":"Gon\u00e7alves JJ, da Mata CPSM, Louren\u00e7o AA, Ribeiro \u00c1L, Ferreira GM, de Fraga-Silva TFC, et al. Timeline kinetics of systemic and airway immune mediator storm for comprehensive analysis of disease outcome in critically Ill COVID-19 patients. Front Immunol. 2022;13:26.","journal-title":"Front Immunol"},{"key":"2085_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1085988","author":"Y-J Lai","year":"2023","unstructured":"Lai Y-J, Liu S-H, Manachevakul S, Lee T-A, Kuo C-T, Bello D. Biomarkers in long COVID-19: a systematic review. Front Med Lausanne. 2023. https:\/\/doi.org\/10.3389\/fmed.2023.1085988.","journal-title":"Front Med Lausanne"},{"key":"2085_CR43","volume":"56","author":"R Chang","year":"2023","unstructured":"Chang R, Chen Y-T, Chen T, Wang S-I, Hung Y-M, Chen H-Y, et al. Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study. EClinicalMedicine. 2023;56:101783.","journal-title":"EClinicalMedicine"},{"key":"2085_CR44","first-page":"9695","volume":"24","author":"R Bonometti","year":"2020","unstructured":"Bonometti R, Sacchi MC, Stobbione P, Lauritano EC, Tamiazzo S, Marchegiani A, et al. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci. 2020;24:9695\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2085_CR45","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2023-eular.4875","volume":"82","author":"L De Stefano","year":"2023","unstructured":"De Stefano L, Rossi S, Montecucco C, Bugatti S. Transient monoarthritis and psoriatic skin lesions following COVID-19. Ann Rheum Dis. 2023;82:e86.","journal-title":"Ann Rheum Dis"},{"key":"2085_CR46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1515\/mr-2024-0013","volume":"4","author":"M Guo","year":"2024","unstructured":"Guo M, Shang S, Li M, Cai G, Li P, Chen X, et al. Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis\/mechanisms of long COVID. Med Rev. 2024;4:367\u201383.","journal-title":"Med Rev"},{"key":"2085_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1298004","author":"L M\u00fcller","year":"2023","unstructured":"M\u00fcller L, Di Benedetto S. From aging to long COVID: exploring the convergence of immunosenescence, inflammaging, and autoimmunity. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1298004.","journal-title":"Front Immunol"},{"key":"2085_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/oxfimm\/iqad002","author":"F-Z El-Rhermoul","year":"2023","unstructured":"El-Rhermoul F-Z, Fedorowski A, Eardley P, Taraborrelli P, Panagopoulos D, Sutton R, et al. Autoimmunity in long covid and POTS. Oxf Open Immunol. 2023. https:\/\/doi.org\/10.1093\/oxfimm\/iqad002.","journal-title":"Oxf Open Immunol"},{"key":"2085_CR49","doi-asserted-by":"crossref","first-page":"384","DOI":"10.33588\/rn.7211.2021230","volume":"72","author":"FJ Carod Artal","year":"2021","unstructured":"Carod Artal FJ. S\u00edndrome post-COVID-19: epidemiolog\u00eda, criterios diagn\u00f3sticos y mecanismos patog\u00e9nicos implicados. Rev Neurol. 2021;72:384.","journal-title":"Rev Neurol"},{"key":"2085_CR50","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103071","volume":"21","author":"A Dotan","year":"2022","unstructured":"Dotan A, David P, Arnheim D, Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun Rev. 2022;21:103071.","journal-title":"Autoimmun Rev"},{"key":"2085_CR51","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001735","volume":"7","author":"F Ursini","year":"2021","unstructured":"Ursini F, Ciaffi J, Mancarella L, Lisi L, Brusi V, Cavallari C, et al. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021;7:e001735.","journal-title":"RMD Open"},{"key":"2085_CR52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41380-021-01148-4","volume":"27","author":"SR Bornstein","year":"2022","unstructured":"Bornstein SR, Voit-Bak K, Donate T, Rodionov RN, Gainetdinov RR, Tselmin S, et al. Chronic post-COVID-19 syndrome and chronic fatigue syndrome: is there a role for extracorporeal apheresis? Mol Psychiatry. 2022;27:34\u20137.","journal-title":"Mol Psychiatry"},{"key":"2085_CR53","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41577-023-00904-7","volume":"23","author":"DM Altmann","year":"2023","unstructured":"Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nat Rev Immunol. 2023;23:618\u201334.","journal-title":"Nat Rev Immunol"},{"key":"2085_CR54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajmo.2024.100068","volume":"11","author":"P Koz\u0142owski","year":"2024","unstructured":"Koz\u0142owski P, Leszczy\u0144ska A, Ciepiela O. Long COVID definition, symptoms, risk factors, epidemiology and autoimmunity: a narrative review. Am J Med Open. 2024;11:100068.","journal-title":"Am J Med Open"},{"key":"2085_CR55","doi-asserted-by":"crossref","first-page":"2200970","DOI":"10.1183\/13993003.00970-2022","volume":"8","author":"K Son","year":"2022","unstructured":"Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms. Eur Respir J. 2022;8:2200970.","journal-title":"Eur Respir J"},{"key":"2085_CR56","first-page":"825","volume":"16","author":"AF Almulla","year":"2024","unstructured":"Almulla AF, Maes M, Zhou B, Al-Hakeim HK, Vojdani A. Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms. J Adv Res. 2024;16:825.","journal-title":"J Adv Res"},{"key":"2085_CR57","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103445","volume":"22","author":"FS Seibert","year":"2023","unstructured":"Seibert FS, Stervbo U, Wiemers L, Skrzypczyk S, Hogeweg M, Bertram S, et al. Severity of neurological long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors. Autoimmun Rev. 2023;22:103445.","journal-title":"Autoimmun Rev"},{"key":"2085_CR58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2023.01.006","volume":"109","author":"C Franke","year":"2023","unstructured":"Franke C, Boesl F, Goereci Y, Gerhard A, Schweitzer F, Schroeder M, et al. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome. Brain Behav Immun. 2023;109:139\u201343.","journal-title":"Brain Behav Immun"},{"key":"2085_CR59","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1038\/s41467-022-34068-0","volume":"13","author":"MM Etter","year":"2022","unstructured":"Etter MM, Martins TA, Kulsvehagen L, P\u00f6ssnecker E, Duchemin W, Hogan S, et al. Severe neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat Commun. 2022;13:6777.","journal-title":"Nat Commun"},{"key":"2085_CR60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210\u20136.","journal-title":"Nat Immunol"},{"key":"2085_CR61","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1038\/s41380-023-02084-1","volume":"28","author":"M Achleitner","year":"2023","unstructured":"Achleitner M, Steenblock C, D\u00e4nhardt J, Jarzebska N, Kardashi R, Kanczkowski W, et al. Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis. Mol Psychiatry. 2023;28:2872\u20137.","journal-title":"Mol Psychiatry"},{"key":"2085_CR62","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cytogfr.2024.08.002","volume":"82","author":"A Hromi\u0107-Jahjefendi\u0107","year":"2025","unstructured":"Hromi\u0107-Jahjefendi\u0107 A, Mahmutovi\u0107 L, Sezer A, Be\u0107irevi\u0107 T, Rubio-Casillas A, Redwan EM, et al. The intersection of microbiome and autoimmunity in long COVID-19: current insights and future directions. Cytokine Growth Factor Rev. 2025;82:43\u201354.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2085_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29887","author":"AR Thierry","year":"2024","unstructured":"Thierry AR, Salmon D. Inflammation-, immunothrombosis,- and autoimmune-feedback loops may lead to persistent neutrophil self-stimulation in long COVID. J Med Virol. 2024. https:\/\/doi.org\/10.1002\/jmv.29887.","journal-title":"J Med Virol"},{"key":"2085_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01064","author":"S Gambardella","year":"2019","unstructured":"Gambardella S, Limanaqi F, Ferese R, Biagioni F, Campopiano R, Centonze D, et al. Ccf-mtDNA as a potential link between the brain and immune system in neuro-immunological disorders. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.01064.","journal-title":"Front Immunol"},{"key":"2085_CR65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.med.53.082901.104024","volume":"53","author":"JN Blankson","year":"2002","unstructured":"Blankson JN, Persaud D, Siliciano RF. The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med. 2002;53:557\u201393.","journal-title":"Annu Rev Med"},{"key":"2085_CR66","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/v16030342","volume":"16","author":"D Fournelle","year":"2024","unstructured":"Fournelle D, Mostefai F, Brunet-Ratnasingham E, Poujol R, Grenier J-C, G\u00e1lvez JH, et al. Intra-host evolution analyses in an immunosuppressed patient supports SARS-CoV-2 viral reservoir hypothesis. Viruses. 2024;16:342.","journal-title":"Viruses"},{"key":"2085_CR67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(00)00453-6","volume":"183","author":"S Pradhan","year":"2001","unstructured":"Pradhan S, Gupta RK, Singh MB, Mathur A. Biphasic illness pattern due to early relapse in Japanese-B virus encephalitis. J Neurol Sci. 2001;183:13\u20138.","journal-title":"J Neurol Sci"},{"key":"2085_CR68","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/COH.0000000000000688","volume":"16","author":"K Busman-Sahay","year":"2021","unstructured":"Busman-Sahay K, Starke CE, Nekorchuk MD, Estes JD. Eliminating HIV reservoirs for a cure: the issue is in the tissue. Curr Opin HIV AIDS. 2021;16:200\u20138.","journal-title":"Curr Opin HIV AIDS"},{"key":"2085_CR69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010242","volume":"16","author":"EB Martins","year":"2022","unstructured":"Martins EB, Silva MFB, Tassinari WS, de Bruycker-Nogueira F, Moraes ICV, Rodrigues CDS, et al. Detection of Chikungunya virus in bodily fluids: the INOVACHIK cohort study. PLoS Negl Trop Dis. 2022;16:e0010242.","journal-title":"PLoS Negl Trop Dis"},{"key":"2085_CR70","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1086\/318533","volume":"183","author":"SR Permar","year":"2001","unstructured":"Permar SR, Moss WJ, Ryon JJ, Monze M, Cutts F, Quinn TC, et al. Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. J Infect Dis. 2001;183:532\u20138.","journal-title":"J Infect Dis"},{"key":"2085_CR71","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/infdis\/jiw078","volume":"214","author":"MS Sow","year":"2016","unstructured":"Sow MS, Etard J-F, Baize S, Magassouba N, Faye O, Msellati P, et al. New evidence of long-lasting persistence of Ebola virus genetic material in semen of survivors: table 1. J Infect Dis. 2016;214:1475\u20136.","journal-title":"J Infect Dis"},{"key":"2085_CR72","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1613108","volume":"379","author":"G Paz-Bailey","year":"2018","unstructured":"Paz-Bailey G, Rosenberg ES, Doyle K, Munoz-Jordan J, Santiago GA, Klein L, et al. Persistence of zika virus in body fluids\u2014final report. N Engl J Med. 2018;379:1234\u201343.","journal-title":"N Engl J Med"},{"key":"2085_CR73","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3390\/v15040899","volume":"15","author":"J Costa dos Santos","year":"2023","unstructured":"Costa dos Santos J, Ximenes Rabelo M, Mattana Sebben L, de Souza Carneiro MV, Bosco Lopes Botelho J, Cardoso Neto J, et al. Persistence of SARS-CoV-2 antigens in the nasal mucosa of eight patients with inflammatory rhinopathy for over 80 days following mild COVID-19 diagnosis. Viruses. 2023;15:899.","journal-title":"Viruses"},{"key":"2085_CR74","first-page":"32","volume":"11","author":"TM de Lima","year":"2023","unstructured":"de Lima TM, Martins RB, Miura CS, Souza MVO, Cassiano MHA, Rodrigues TS, et al. Tonsils are major sites of persistence of SARS-CoV-2 in children. Microbiol Spectr. 2023;11:32.","journal-title":"Microbiol Spectr."},{"key":"2085_CR75","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","volume":"612","author":"SR Stein","year":"2022","unstructured":"Stein SR, Ramelli SC, Grazioli A, Chung J-Y, Singh M, Yinda CK, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758\u201363.","journal-title":"Nature"},{"key":"2085_CR76","doi-asserted-by":"crossref","DOI":"10.1097\/PG9.0000000000000152","volume":"3","author":"D Arostegui","year":"2022","unstructured":"Arostegui D, Castro K, Schwarz S, Vaidy K, Rabinowitz S, Wallach T. Persistent SARS-CoV-2 nucleocapsid protein presence in the intestinal epithelium of a pediatric patient 3 months after acute infection. JPGN Rep. 2022;3:e152.","journal-title":"JPGN Rep"},{"key":"2085_CR77","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s41590-023-01601-2","volume":"24","author":"AD Proal","year":"2023","unstructured":"Proal AD, VanElzakker MB, Aleman S, Bach K, Boribong BP, Buggert M, et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). Nat Immunol. 2023;24:1616\u201327.","journal-title":"Nat Immunol"},{"key":"2085_CR78","volume":"45","author":"C Han","year":"2024","unstructured":"Han C, Wang H, Wang Y, Hang C, Wang Y, Meng X. The silent reservoir? SARS-CoV-2 detection in the middle ear effusion of patients with otitis media with effusion after omicron infection. Am J Otolaryngol. 2024;45:104229.","journal-title":"Am J Otolaryngol"},{"key":"2085_CR79","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13060905","volume":"13","author":"N Rubicz","year":"2023","unstructured":"Rubicz N, Poier-Fabian N, Paar C, Winkler-Zamani M, Hermann P, Raidl S, et al. SARS-CoV-2 in the middle ear-covear: a prospective pilot study. J Pers Med. 2023;13:905.","journal-title":"J Pers Med"},{"key":"2085_CR80","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12105-021-01378-6","volume":"16","author":"A Kurabi","year":"2022","unstructured":"Kurabi A, Pak K, DeConde AS, Ryan AF, Yan CH. Immunohistochemical and qPCR detection of SARS-CoV-2 in the human middle ear versus the nasal cavity: case series. Head Neck Pathol. 2022;16:607\u201311.","journal-title":"Head Neck Pathol"},{"key":"2085_CR81","volume":"2018","author":"G Li","year":"2018","unstructured":"Li G, You D, Ma J, Li W, Li H, Sun S. The role of autoimmunity in the pathogenesis of sudden sensorineural hearing loss. Neural Plast. 2018;2018:2018:1\u20139.","journal-title":"Neural Plast"},{"key":"2085_CR82","volume":"15","author":"DE Safadi","year":"2023","unstructured":"Safadi DE, Lebeau G, Lagrave A, M\u00e9lade J, Grondin L, Rosanaly S, et al. Extracellular vesicles are conveyors of the NS1 toxin during Dengue virus and Zika virus infection. Viruses. 2023;15:364.","journal-title":"Viruses"},{"key":"2085_CR83","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fimmu.2016.00397","volume":"7","author":"C Marban","year":"2016","unstructured":"Marban C, Forouzanfar F, Ait-Ammar A, Fahmi F, El Mekdad H, Daouad F, et al. Targeting the brain reservoirs: toward an HIV Cure. Front Immunol. 2016;7:16.","journal-title":"Front Immunol"},{"key":"2085_CR84","doi-asserted-by":"crossref","first-page":"25254","DOI":"10.1073\/pnas.2010722117","volume":"117","author":"MH Cheng","year":"2020","unstructured":"Cheng MH, Zhang S, Porritt RA, Noval Rivas M, Paschold L, Willscher E, et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc Natl Acad Sci. 2020;117:25254\u201362.","journal-title":"Proc Natl Acad Sci"},{"key":"2085_CR85","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506.","journal-title":"Lancet"},{"key":"2085_CR86","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/cei.13547","volume":"203","author":"S Cantenys-Molina","year":"2021","unstructured":"Cantenys-Molina S, Fern\u00e1ndez-Cruz E, Francos P, Lopez Bernaldo de Quir\u00f3s JC, Mu\u00f1oz P, Gil-Herrera J. Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain. Clin Exp Immunol. 2021;203:424\u201332.","journal-title":"Clin Exp Immunol"},{"key":"2085_CR87","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12890-023-02767-z","volume":"23","author":"G Chen","year":"2023","unstructured":"Chen G, Zhao X, Chen X, Liu C. Early decrease in blood lymphocyte count is associated with poor prognosis in COVID-19 patients: a retrospective cohort study. BMC Pulm Med. 2023;23:453.","journal-title":"BMC Pulm Med"},{"key":"2085_CR88","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/NDT.S387501","volume":"19","author":"L Taruffi","year":"2023","unstructured":"Taruffi L, Muccioli L, Mitolo M, Ferri L, Descovich C, Mazzoni S, et al. Neurological manifestations of long COVID: a single-center one-year experience. Neuropsychiatr Dis Treat. 2023;19:311\u20139.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2085_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2423","author":"J Gerlach","year":"2023","unstructured":"Gerlach J, Baig AM, Fabrowski M, Viduto V. The immune paradox of SARS-CoV-2: lymphocytopenia and autoimmunity evoking features in COVID-19 and possible treatment modalities. Rev Med Virol. 2023. https:\/\/doi.org\/10.1002\/rmv.2423.","journal-title":"Rev Med Virol"},{"key":"2085_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.931039","author":"M Govender","year":"2022","unstructured":"Govender M, Hopkins FR, G\u00f6ransson R, Svanberg C, Shankar EM, Hjorth M, et al. T cell perturbations persist for at least 6 months following hospitalization for COVID-19. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.931039.","journal-title":"Front Immunol"},{"issue":"383","key":"2085_CR91","first-page":"262","volume":"2024","author":"W Ruf","year":"1979","unstructured":"Ruf W. Immune damage in long covid. Science. 1979;2024(383):262\u20133.","journal-title":"Science"},{"key":"2085_CR92","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10020242","volume":"10","author":"D Kudlay","year":"2022","unstructured":"Kudlay D, Kofiadi I, Khaitov M. Peculiarities of the T cell immune response in COVID-19. Vaccines. 2022;10:242.","journal-title":"Vaccines"},{"key":"2085_CR93","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.immuni.2021.05.010","volume":"54","author":"L Bergamaschi","year":"2021","unstructured":"Bergamaschi L, Mescia F, Turner L, Hanson AL, Kotagiri P, Dunmore BJ, et al. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity. 2021;54:1257-1275.e8.","journal-title":"Immunity"},{"key":"2085_CR94","first-page":"14","volume":"8","author":"\u00c1 Lopes-Ribeiro","year":"2023","unstructured":"Lopes-Ribeiro \u00c1, de Oliveira PM, Retes HM, Barbosa-Stancioli EF, da Fonseca FG, Tsuji M, et al. Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8+ T cells. Front Immunol. 2023;8:14.","journal-title":"Front Immunol"},{"key":"2085_CR95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010359","volume":"18","author":"KM Littlefield","year":"2022","unstructured":"Littlefield KM, Watson RO, Schneider JM, Neff CP, Yamada E, Zhang M, et al. SARS-CoV-2-specific t cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 2022;18:e1010359.","journal-title":"PLoS Pathog"},{"key":"2085_CR96","first-page":"987","volume":"7","author":"A Arcanjo","year":"2021","unstructured":"Arcanjo A, Guimar\u00e3es Pinto K, Logullo J, Leite PEC, Menezes CCB, Freire-de-Lima L, et al. Critically ill coronavirus disease 2019 patients exhibit hyperactive cytokine responses associated with effector exhausted senescent T cells in acute infection. J Infect Dis. 2021;7:987.","journal-title":"J Infect Dis"},{"key":"2085_CR97","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.86014","author":"S Mohandas","year":"2023","unstructured":"Mohandas S, Jagannathan P, Henrich TJ, Sherif ZA, Bime C, Quinlan E, et al. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023. https:\/\/doi.org\/10.7554\/eLife.86014.","journal-title":"Elife"},{"key":"2085_CR98","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fmicb.2023.1196721","volume":"14","author":"K Paniskaki","year":"2023","unstructured":"Paniskaki K, Konik MJ, Anft M, Heidecke H, Meister TL, Pfaender S, et al. Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19. Front Microbiol. 2023;14:32.","journal-title":"Front Microbiol"},{"key":"2085_CR99","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1084\/jem.189.4.701","volume":"189","author":"DH Busch","year":"1999","unstructured":"Busch DH, Pamer EG. T cell affinity maturation by selective expansion during infection. J Exp Med. 1999;189:701\u201310.","journal-title":"J Exp Med"},{"key":"2085_CR100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1074-7613(00)80048-5","volume":"10","author":"PA Savage","year":"1999","unstructured":"Savage PA, Boniface JJ, Davis MM. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity. 1999;10:485\u201392.","journal-title":"Immunity"},{"key":"2085_CR101","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s41590-018-0160-9","volume":"19","author":"AC Richard","year":"2018","unstructured":"Richard AC, Lun ATL, Lau WWY, G\u00f6ttgens B, Marioni JC, Griffiths GM. T cell cytolytic capacity is independent of initial stimulation strength. Nat Immunol. 2018;19:849\u201358.","journal-title":"Nat Immunol"},{"key":"2085_CR102","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/icb.2015.44","volume":"93","author":"T Cukalac","year":"2015","unstructured":"Cukalac T, Kan W, Dash P, Guan J, Quinn KM, Gras S, et al. Paired TCR\u03b1\u03b2 analysis of virus-specific CD8 + T cells exposes diversity in a previously defined \u2018narrow\u2019 repertoire. Immunol Cell Biol. 2015;93:804\u201314.","journal-title":"Immunol Cell Biol"},{"key":"2085_CR103","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.4049\/jimmunol.1500639","volume":"196","author":"SM Krummey","year":"2016","unstructured":"Krummey SM, Martinez RJ, Andargachew R, Liu D, Wagener M, Kohlmeier JE, et al. Low-affinity memory CD8+ T cells mediate robust heterologous immunity. J Immunol. 2016;196:2838\u201346.","journal-title":"J Immunol"},{"key":"2085_CR104","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41590-020-0628-2","volume":"21","author":"K Schober","year":"2020","unstructured":"Schober K, Voit F, Grassmann S, M\u00fcller TR, Eggert J, Jarosch S, et al. Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection. Nat Immunol. 2020;21:434\u201341.","journal-title":"Nat Immunol"},{"key":"2085_CR105","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0773-z","volume":"7","author":"MN Duong","year":"2019","unstructured":"Duong MN, Erdes E, Hebeisen M, Rufer N. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes. J Immunother Cancer. 2019;7:284.","journal-title":"J Immunother Cancer"},{"key":"2085_CR106","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/acel.13067","volume":"19","author":"LA Callender","year":"2020","unstructured":"Callender LA, Carroll EC, Bober EA, Akbar AN, Solito E, Henson SM. Mitochondrial mass governs the extent of human T cell senescence. Aging Cell. 2020;19:97.","journal-title":"Aging Cell"},{"key":"2085_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1155770","author":"L Visvabharathy","year":"2023","unstructured":"Visvabharathy L, Hanson BA, Orban ZS, Lim PH, Palacio NM, Jimenez M, et al. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 nucleocapsid protein. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1155770.","journal-title":"Front Immunol"},{"key":"2085_CR108","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.2009.03960.x","volume":"157","author":"G Rosignoli","year":"2009","unstructured":"Rosignoli G, Lim CH, Bower M, Gotch F, Imami N. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals. Clin Exp Immunol. 2009;157:90\u20137.","journal-title":"Clin Exp Immunol"},{"key":"2085_CR109","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1128\/JVI.00045-07","volume":"81","author":"JW Northfield","year":"2007","unstructured":"Northfield JW, Loo CP, Barbour JD, Spotts G, Hecht FM, Klenerman P, et al. Human immunodeficiency virus type 1 (HIV-1)-specific CD8 + T EMRA cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. J Virol. 2007;81:5759\u201365.","journal-title":"J Virol"},{"key":"2085_CR110","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1128\/JVI.02892-15","volume":"90","author":"R de Alwis","year":"2016","unstructured":"de Alwis R, Bangs DJ, Angelo MA, Cerpas C, Fernando A, Sidney J, et al. Immunodominant dengue virus-specific CD8 + T cell responses are associated with a memory PD-1 + phenotype. J Virol. 2016;90:4771\u20139.","journal-title":"J Virol"},{"key":"2085_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00479","author":"N Graham","year":"2020","unstructured":"Graham N, Eisenhauer P, Diehl SA, Pierce KK, Whitehead SS, Durbin AP, et al. Rapid induction and maintenance of virus-specific CD8+ TEMRA and CD4+ TEM cells following protective vaccination against dengue virus challenge in humans. Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.00479.","journal-title":"Front Immunol"},{"key":"2085_CR112","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41514-019-0041-y","volume":"6","author":"C Martin-Ruiz","year":"2020","unstructured":"Martin-Ruiz C, Hoffmann J, Shmeleva E, von Zglinicki T, Richardson G, Draganova L, et al. CMV-independent increase in CD27\u2212CD28+ CD8+ EMRA T cells is inversely related to mortality in octogenarians. NPJ Aging Mech Dis. 2020;6:3.","journal-title":"NPJ Aging Mech Dis"},{"key":"2085_CR113","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104507","volume":"90","author":"H Xiong","year":"2023","unstructured":"Xiong H, Cui M, Kong N, Jing J, Xu Y, Liu X, et al. Cytotoxic CD161\u2212CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus. EBioMedicine. 2023;90:104507.","journal-title":"EBioMedicine"},{"key":"2085_CR114","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004754","author":"S Reinke","year":"2013","unstructured":"Reinke S, Geissler S, Taylor WR, Schmidt-Bleek K, Juelke K, Schwachmeyer V, et al. Terminally differentiated CD8 + T cells negatively affect bone regeneration in humans. Sci Transl Med. 2013. https:\/\/doi.org\/10.1126\/scitranslmed.3004754.","journal-title":"Sci Transl Med"},{"key":"2085_CR115","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1038\/s41467-024-47720-8","volume":"15","author":"C Phetsouphanh","year":"2024","unstructured":"Phetsouphanh C, Jacka B, Ballouz S, Jackson KJL, Wilson DB, Manandhar B, et al. Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection. Nat Commun. 2024;15:3315.","journal-title":"Nat Commun"},{"key":"2085_CR116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jim-2021-002051","volume":"70","author":"P Glynne","year":"2022","unstructured":"Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Invest Med. 2022;70:61\u20137.","journal-title":"J Invest Med"},{"key":"2085_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886431","author":"M Wiech","year":"2022","unstructured":"Wiech M, Chroscicki P, Swatler J, Stepnik D, De Biasi S, Hampel M, et al. Remodeling of t cell dynamics during long COVID is dependent on severity of SARS-CoV-2 infection. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.886431.","journal-title":"Front Immunol"},{"key":"2085_CR118","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","volume":"623","author":"J Klein","year":"2023","unstructured":"Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139\u201348.","journal-title":"Nature"},{"key":"2085_CR119","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1038\/s41467-019-12446-5","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen Y, Yu M, Zheng Y, Fu G, Xin G, Zhu W, et al. CXCR5+PD-1+ follicular helper CD8 T cells control B cell tolerance. Nat Commun. 2019;10:4415.","journal-title":"Nat Commun"},{"key":"2085_CR120","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbrc.2012.04.133","volume":"422","author":"X Li","year":"2012","unstructured":"Li X, Wu Z, Ding J, Zheng Z, Li X, Chen L, et al. Role of the frequency of blood CD4+ CXCR5+ CCR6+ T cells in autoimmunity in patients with Sj\u00f6gren\u2019s syndrome. Biochem Biophys Res Commun. 2012;422:238\u201344.","journal-title":"Biochem Biophys Res Commun"},{"key":"2085_CR121","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41590-023-01724-6","volume":"25","author":"K Yin","year":"2024","unstructured":"Yin K, Peluso MJ, Luo X, Thomas R, Shin M-G, Neidleman J, et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 2024;25:218\u201325.","journal-title":"Nat Immunol"},{"key":"2085_CR122","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41590-023-01510-4","volume":"24","author":"M K\u00fcnzli","year":"2023","unstructured":"K\u00fcnzli M, Masopust D. CD4+ T cell memory. Nat Immunol. 2023;24:903\u201314.","journal-title":"Nat Immunol"},{"key":"2085_CR123","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, Lenig D, F\u00f6rster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708\u201312.","journal-title":"Nature"},{"key":"2085_CR124","doi-asserted-by":"crossref","first-page":"20453","DOI":"10.1073\/pnas.1008437107","volume":"107","author":"S Han","year":"2010","unstructured":"Han S, Asoyan A, Rabenstein H, Nakano N, Obst R. Role of antigen persistence and dose for CD4 + T-cell exhaustion and recovery. Proc Natl Acad Sci U S A. 2010;107:20453\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2085_CR125","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109518","volume":"36","author":"MJ Peluso","year":"2021","unstructured":"Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36:109518.","journal-title":"Cell Rep"},{"key":"2085_CR126","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/10815589231158041","volume":"71","author":"S Opsteen","year":"2023","unstructured":"Opsteen S, Files JK, Fram T, Erdmann N. The role of immune activation and antigen persistence in acute and long COVID. J Invest Med. 2023;71:545\u201362.","journal-title":"J Invest Med"},{"key":"2085_CR127","doi-asserted-by":"crossref","first-page":"11759","DOI":"10.3390\/ijms252111759","volume":"25","author":"A Aquino","year":"2024","unstructured":"Aquino A, Zaikova E, Kalinina O, Karonova TL, Rubinstein A, Mikhaylova AA, et al. T regulatory cell subsets do not restore for one year after acute COVID-19. Int J Mol Sci. 2024;25:11759.","journal-title":"Int J Mol Sci"},{"key":"2085_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1070994","author":"S Haunhorst","year":"2022","unstructured":"Haunhorst S, Bloch W, Javelle F, Kr\u00fcger K, Baumgart S, Drube S, et al. A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients\u2014indications for their potential involvement in the development of long COVID? Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.1070994.","journal-title":"Front Immunol"},{"key":"2085_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030699","author":"M Dhawan","year":"2023","unstructured":"Dhawan M, Rabaan AA, Alwarthan S, Alhajri M, Halwani MA, Alshengeti A, et al. Regulatory T cells (Tregs) and COVID-19: unveiling the mechanisms, and therapeutic potentialities with a special focus on long COVID. Vaccines. 2023. https:\/\/doi.org\/10.3390\/vaccines11030699.","journal-title":"Vaccines"},{"key":"2085_CR130","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061550","volume":"10","author":"D Martonik","year":"2021","unstructured":"Martonik D, Parfieniuk-Kowerda A, Rogalska M, Flisiak R. The role of Th17 response in COVID-19. Cells. 2021;10:1550.","journal-title":"Cells"},{"key":"2085_CR131","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/jcp.30047","volume":"236","author":"A Sadeghi","year":"2021","unstructured":"Sadeghi A, Tahmasebi S, Mahmood A, Kuznetsova M, Valizadeh H, Taghizadieh A, et al. Expression of concern: Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls. J Cell Physiol. 2021;236:2829\u201339.","journal-title":"J Cell Physiol"},{"key":"2085_CR132","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123\u201332.","journal-title":"Nat Immunol"},{"key":"2085_CR133","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang Y-H, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133\u201341.","journal-title":"Nat Immunol"},{"key":"2085_CR134","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007;13:1173\u20135.","journal-title":"Nat Med"},{"key":"2085_CR135","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2025813118","author":"C Larochelle","year":"2021","unstructured":"Larochelle C, Wasser B, Jamann H, L\u00f6ffel JT, Cui Q-L, Tastet O, et al. Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammation. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2025813118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2085_CR136","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1038\/s41598-024-55696-0","volume":"14","author":"MAF Queiroz","year":"2024","unstructured":"Queiroz MAF, dos Brito WRS, Pereira KAS, Pereira LMS, da Amoras ESG, Lima SS, et al. Severe COVID-19 and long COVID are associated with high expression of STING, cGAS and IFN-\u03b1. Sci Rep. 2024;14:4974.","journal-title":"Sci Rep"},{"key":"2085_CR137","first-page":"16","volume":"12","author":"MAF Queiroz","year":"2022","unstructured":"Queiroz MAF, das Neves PFM, Lima SS, da Lopes JC, da Torres MKS, Vallinoto IMVC, et al. Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infect Microbiol. 2022;12:16.","journal-title":"Front Cell Infect Microbiol"},{"key":"2085_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.848886","author":"M Gal\u00e1n","year":"2022","unstructured":"Gal\u00e1n M, Vig\u00f3n L, Fuertes D, Murciano-Ant\u00f3n MA, Casado-Fern\u00e1ndez G, Dom\u00ednguez-Mateos S, et al. Persistent overactive cytotoxic immune response in a Spanish cohort of individuals with Long-COVID: identification of diagnostic biomarkers. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.848886.","journal-title":"Front Immunol"},{"key":"2085_CR139","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.it.2024.10.004","volume":"45","author":"V D\u2019Onofrio","year":"2024","unstructured":"D\u2019Onofrio V, S\u00e9kaly RP. The immune\u2013endocrine interplay in sex differential responses to viral infection and COVID-19. Trends Immunol. 2024;45:943\u201358.","journal-title":"Trends Immunol"},{"key":"2085_CR140","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1125246","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Jiao B, Qu L, Yang D, Liu R. The development of COVID-19 treatment. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1125246.","journal-title":"Front Immunol"},{"issue":"11","key":"2085_CR141","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1007\/s11033-022-07822-2","volume":"49","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Batiha GE. Nitazoxanide and COVID-19: a review. Mol Biol Rep. 2022;49(11):11169\u201376.","journal-title":"Mol Biol Rep"},{"key":"2085_CR142","unstructured":"CDC. Clinical overview of long COVID. 2025. https:\/\/www.cdc.gov\/covid\/hcp\/clinical-overview\/index.html."},{"key":"2085_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.809244","author":"P Mistry","year":"2022","unstructured":"Mistry P, Barmania F, Mellet J, Peta K, Strydom A, Viljoen IM, et al. SARS-CoV-2 variants, vaccines, and host immunity. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2021.809244.","journal-title":"Front Immunol"},{"key":"2085_CR144","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.vaccine.2023.02.008","volume":"41","author":"A Watanabe","year":"2023","unstructured":"Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine. 2023;41:1783\u201390.","journal-title":"Vaccine"},{"key":"2085_CR145","doi-asserted-by":"crossref","first-page":"e0283983","DOI":"10.1371\/journal.pone.0283983","volume":"18","author":"SMR Gomes","year":"2023","unstructured":"Gomes SMR, de Brito ACS, Manfro WFP, Ribeiro-Alves M, de Ribeiro RSA, da Cal MS, et al. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients. PLoS ONE. 2023;18:e0283983.","journal-title":"PLoS ONE"},{"key":"2085_CR146","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40249-023-01086-z","volume":"12","author":"J-X Yin","year":"2023","unstructured":"Yin J-X, Agbana YL, Sun Z-S, Fei S-W, Zhao H-Q, Zhou X-N, et al. Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis. Infect Dis Poverty. 2023;12:43.","journal-title":"Infect Dis Poverty"},{"key":"2085_CR147","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","volume":"603","author":"J DiDomizio","year":"2022","unstructured":"DiDomizio J, Gulen MF, Saidoune F, Thacker VV, Yatim A, Sharma K, et al. The cGAS\u2013STING pathway drives type i IFN immunopathology in COVID-19. Nature. 2022;603:145\u201351.","journal-title":"Nature"},{"issue":"3","key":"2085_CR148","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10787-022-00993-1","volume":"30","author":"G Mostafa-Hedeab","year":"2022","unstructured":"Mostafa-Hedeab G, Al-Kuraishy HM, Al-Gareeb AI, Jeandet P, Saad HM, Batiha GE. A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19. Inflammopharmacology. 2022;30(3):799\u2013809.","journal-title":"Inflammopharmacology"},{"key":"2085_CR149","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12967-022-03488-3","volume":"20","author":"A Cash","year":"2022","unstructured":"Cash A, Kaufman DL. Oxaloacetate treatment for mental and physical fatigue in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS) and long-COVID fatigue patients: a non-randomized controlled clinical trial. J Transl Med. 2022;20:295.","journal-title":"J Transl Med"},{"key":"2085_CR150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12944-024-02090-4","volume":"23","author":"UN Das","year":"2024","unstructured":"Das UN. Can essential fatty acids (EFAs) prevent and ameliorate post-COVID-19 long haul manifestations? Lipids Health Dis. 2024;23:112.","journal-title":"Lipids Health Dis"},{"key":"2085_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1457672","author":"X He","year":"2024","unstructured":"He X, Zhang X, Zhong W. Emerging small-molecule antiviral agents in long COVID prevention. Front Pharmacol. 2024. https:\/\/doi.org\/10.3389\/fphar.2024.1457672.","journal-title":"Front Pharmacol"},{"key":"2085_CR152","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s43856-024-00668-8","volume":"4","author":"AK Cohen","year":"2025","unstructured":"Cohen AK, Jaudon TW, Schurman EM, Kava L, Vogel JM, Haas-Godsil J, et al. Impact of extended-course oral nirmatrelvir\/ritonavir in established long COVID: a case series. Commun Med. 2025;4:261.","journal-title":"Commun Med"},{"key":"2085_CR153","doi-asserted-by":"crossref","first-page":"19688","DOI":"10.1038\/s41598-023-46912-4","volume":"13","author":"S Congdon","year":"2023","unstructured":"Congdon S, Narrowe Z, Yone N, Gunn J, Deng Y, Nori P, et al. Nirmatrelvir\/ritonavir and risk of long COVID symptoms: a retrospective cohort study. Sci Rep. 2023;13:19688.","journal-title":"Sci Rep"},{"key":"2085_CR154","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/v16030450","volume":"16","author":"F Samarelli","year":"2024","unstructured":"Samarelli F, Graziano G, Gambacorta N, Graps E, Leonetti F, Nicolotti O, et al. Small molecules for the treatment of Long-COVID-related vascular damage and abnormal blood clotting: a patent-based appraisal. Viruses. 2024;16:450.","journal-title":"Viruses"},{"key":"2085_CR155","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41591-021-01402-w","volume":"27","author":"Z Amin-Chowdhury","year":"2021","unstructured":"Amin-Chowdhury Z, Ladhani SN. Causation or confounding: why controls are critical for characterizing long COVID. Nat Med. 2021;27:1129\u201330.","journal-title":"Nat Med"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02085-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02085-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02085-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:10:43Z","timestamp":1779797443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02085-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":155,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2085"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02085-6","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"127"}}